Basilea Pharmaceutica AG (SWX: BSLN)
Switzerland
· Delayed Price · Currency is CHF
41.50
+0.15 (0.36%)
Jan 3, 2025, 5:31 PM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 503.03 million as of January 3, 2025. Its market cap has increased by 18.78% in one year.
Market Cap
503.03M
Enterprise Value
552.51M
Revenue
149.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
41.50
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has decreased from 533.29M to 503.03M, a decrease of -5.68%. That is a compound annual growth rate of -0.28%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Roche Holding AG | 205.19B |
Novartis AG | 177.34B |
Lonza Group AG | 38.70B |
Alcon | 38.03B |
Galderma Group AG | 23.91B |
Straumann Holding AG | 18.22B |
Sonova Holding AG | 17.66B |
Sandoz Group AG | 16.31B |